Lajthia E, Bucheit JD, Nadpara PA, Dixon DL, Caldas LM, Murchie M, et al
By the 1990s it had become apparent that GLP-1 not only played an important role in the stimulation of insulin but could also have broader physiological actions beyond the pancreas
The combined effect of slowed digestion, reduced appetite, and increased satiety from GLP-1 and protein can significantly support weight loss efforts
Interestingly, according to the International Diabetes Federation (IDF) assessment, the prevalence of diabetes is currently slightly higher in men than in women
In their marketing, telehealth companies claim that compounded GLP-1s in small doses starting lower than FDA-approved doses from Novo Nordisk and Eli Lilly can reduce metabolic risk, lower inflammatory markers, and even lower the risk of cognitive decline